SLC2A4 and type 2 diabetes mellitus: Regarding T2DM, it has been described how ADMSCs may improve insulin resistance, as they may activate different signaling pathways, including GLUT-4 signaling and PPAR-γ activation, as they may decrease pro-inflammatory cytokines and insulin desensitizing adipokines secretion.